FR3013049B1 - Analogue de l'insuline glargine - Google Patents

Analogue de l'insuline glargine

Info

Publication number: FR3013049B1
Authority: FR; France
Prior art keywords: analogue; insulin glargine; glargine; insulin
Prior art date: 2013-11-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR1361127A

Other languages

English (en)

Other versions

FR3013049A1 (fr

Inventor

Corine Vialas

Maximilien Blas

You-Ping Chan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-11-14

Filing date

2013-11-14

Publication date

2015-11-13

2013-11-14 Application filed by Individual filed Critical Individual

2013-11-14 Priority to FR1361127A priority Critical patent/FR3013049B1/fr

2014-11-13 Priority to PCT/EP2014/074508 priority patent/WO2015071368A1/fr

2015-05-15 Publication of FR3013049A1 publication Critical patent/FR3013049A1/fr

2015-11-13 Application granted granted Critical

2015-11-13 Publication of FR3013049B1 publication Critical patent/FR3013049B1/fr

Status Expired - Fee Related legal-status Critical Current

2033-11-14 Anticipated expiration legal-status Critical

Links

COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Emergency Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

FR1361127A 2013-11-14 2013-11-14 Analogue de l'insuline glargine Expired - Fee Related FR3013049B1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
FR1361127A FR3013049B1 (fr)	2013-11-14	2013-11-14	Analogue de l'insuline glargine
PCT/EP2014/074508 WO2015071368A1 (fr)	2013-11-14	2014-11-13	Analogue de l'insuline glargine à action prolongée

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1361127A FR3013049B1 (fr)	2013-11-14	2013-11-14	Analogue de l'insuline glargine

Publications (2)

Publication Number	Publication Date
FR3013049A1 FR3013049A1 (fr)	2015-05-15
FR3013049B1 true FR3013049B1 (fr)	2015-11-13

Family

ID=50482902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1361127A Expired - Fee Related FR3013049B1 (fr)	2013-11-14	2013-11-14	Analogue de l'insuline glargine

Country Status (2)

Country	Link
FR (1)	FR3013049B1 (fr)
WO (1)	WO2015071368A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2010009850A (es)	2008-03-18	2010-09-30	Novo Nordisk As	Analogos de insulina acilados y etabilizados contra proteasas.
MA49116A (fr)	2016-12-16	2020-03-25	Novo Nordisk As	Compositions pharmaceutiques contenant de l'insuline

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5646242A (en)	1994-11-17	1997-07-08	Eli Lilly And Company	Selective acylation of epsilon-amino groups
US5656772A (en)	1996-07-19	1997-08-12	Markel; Philip A.	Gas pressure gauge clamp
DK0821006T3 (da)	1996-07-26	2004-08-16	Aventis Pharma Gmbh	Insulinderivater med öget zinkbinding
DE19825447A1 (de)	1998-06-06	1999-12-09	Hoechst Marion Roussel De Gmbh	Neue Insulinanaloga mit erhöhter Zinkbildung
BR0215029A (pt)	2001-12-20	2005-12-20	Lilly Co Eli	Molécula de insulina, uso da mesma, composição, uso desta, microcristal, processo para prepará-lo, uso deste, e, métodos para preparar uma molécula de insulina, para tratar hiperglicemia, e para tratar diabetes mellitus
US20060217290A1 (en)	2003-04-29	2006-09-28	Kohn Wayne D	Insulin analogs having protracted time action
KR101159559B1 (ko)	2003-08-05	2012-06-26	노보 노르디스크 에이/에스	신규의 인슐린 유도체
WO2006008238A1 (fr) *	2004-07-16	2006-01-26	Novo Nordisk A/S	Procede d'acylation selective
JP5410020B2 (ja) *	2005-02-02	2014-02-05	ノヴォノルディスクアー／エス	インスリン誘導体
EP2049149B1 (fr) *	2006-07-31	2015-04-15	Novo Nordisk A/S	Insulines pegylées à extensions
US20120214965A1 (en)	2011-02-23	2012-08-23	Elona Biotechnologies	Glargine proinsulin and methods of producing glargine insulin analogs therefrom
KR20100053561A (ko) *	2007-08-15	2010-05-20	노보 노르디스크 에이/에스	아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
EP2242767A4 (fr)	2008-02-19	2011-04-06	Biocon Ltd	Procédé d'obtention d'insulines hétérologues purifiées s'exprimant dans des levures

2013
- 2013-11-14 FR FR1361127A patent/FR3013049B1/fr not_active Expired - Fee Related
2014
- 2014-11-13 WO PCT/EP2014/074508 patent/WO2015071368A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2015071368A1 (fr)	2015-05-21
FR3013049A1 (fr)	2015-05-15

Publication	Publication Date	Title
DK2963056T3 (da)	2020-02-17	Insulinanalog og anvendelse deraf
EP2900255A4 (fr)	2016-06-22	Dimères analogues de l'insuline
CL2015003031A1 (es)	2016-06-24	Compuesto peptídico
EP2982689A4 (fr)	2016-11-02	Variant de région fc
DK3587448T3 (da)	2021-08-09	Heterodimere proteiner
FI20135915L (fi)	2015-03-12	Parannettu gyroskooppirakenne ja gyroskooppi
DK3057983T3 (da)	2020-02-17	Glucagon-analoger
UA29014S (uk)	2015-03-25	Комп'ютер
DK2968443T3 (da)	2021-12-06	Hepcidinanaloger og anvendelser deraf
EP2968569A4 (fr)	2016-11-02	Formulation à mâcher
EP2974879A4 (fr)	2016-10-12	Corps d'écran
LT3060577T (lt)	2021-12-27	Rekombinantinio lubricino gamyba
DK3088054T3 (da)	2020-10-19	Bold
HUE042796T2 (hu)	2019-07-29	Rögzített glargin inzulin/lixiszenatid arányú készítmény
DK3000133T3 (da)	2021-04-26	Piezoelektrisk føler
EP2956133A4 (fr)	2016-12-21	Acides tétrahydrocannabinol-11-oïques ultrapurs
EP2948469A4 (fr)	2016-11-02	Polypeptide c ur d'hépatite b stabilisé
EP2968473A4 (fr)	2016-11-23	Analogues d'insuline de site 2
LT3063287T (lt)	2025-05-26	Monensino naudojimas rekombinantinių baltymų glikozilinimui reguliuoti
EP2956160A4 (fr)	2016-08-03	Polypeptides sécréteurs d'insuline
FR3013049B1 (fr)	2015-11-13	Analogue de l'insuline glargine
EP3044276A4 (fr)	2016-09-07	Composition adhésive précéramique
DK2983690T3 (da)	2019-05-20	Neuropeptid Y-afledte peptider
FR3008725B1 (fr)	2015-08-07	Monument funeraire
BR302014002438S1 (pt)	2015-07-07	Configuração aplicada a um inalador

Legal Events

Date	Code	Title	Description
2015-09-29	PLFP	Fee payment	Year of fee payment: 3
2016-11-25	PLFP	Fee payment	Year of fee payment: 4
2017-09-27	PLFP	Fee payment	Year of fee payment: 5
2018-09-27	PLFP	Fee payment	Year of fee payment: 6
2020-10-16	ST	Notification of lapse	Effective date: 20200910